Skip to content

AbbVie ABBV Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Eli Lilly logo
Eli LillyLLY
$0-100%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$0-100%
Amgen logo
AmgenAMGN
$3.96B
Bausch Health Companies logo
Bausch Health CompaniesBHC
$2.8B+5,504%
McKesson logo
McKessonMCK
$1.99B
Cencora logo
CencoraCOR

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$447.62B+36.6%
P/E123.1×+36.0×
P/S7.1×+1.5×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's debt issuance proceeds?
AbbVie (ABBV) reported debt issuance proceeds of $7.99B in Q1 2026.
How has AbbVie's debt issuance proceeds changed year-over-year?
AbbVie's debt issuance proceeds increased by 100.1% year-over-year, from $3.99B to $7.99B.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.